Roy E Smith - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Roy E Smith

Showing results (21-30 of 40) with videos related to

Pageof 4

Sort By:

Cancer|September 14, 2007

Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysisJ Philip Kuebler, Linda Colangelo, Michael J O'Connell, et al.

Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 24, 2018

The American Society of Hematology (ASH) Medical Educators Institute: a Pilot Faculty Development Project for Hematology EducatorsJennifer C Kesselheim, Charles P Clayton, Josel Fritz, et al.

Clinical Breast Cancer|January 21, 2003

Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58Roy E Smith, Stewart J Anderson, Ann Brown, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 23, 2015

Plasma from chronic liver disease subjects exhibit differential ability to generate thrombinZhineng J Yang, Siddharth H Sheth, Chad H Smith, et al.

Microsurgery|February 27, 2023

Association between venous thromboembolism rates and different prophylactic anticoagulation regimens in patients undergoing free flap reconstruction of the head and neck regionRakan Saadoun, Fuat Baris Bengur, Elizabeth A Moroni, et al.

Journal of the American Heart Association|August 25, 2021

Association Between Black Race, Clinical Severity, and Management of Acute Pulmonary Embolism: A Retrospective Cohort StudyAmanda R Phillips, Katherine M Reitz, Sara Myers, et al.

Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|July 24, 2009

Validation of a protocol for the assessment of skin temperature and blood flow in childhood localised sclerodermaKevin J Howell, Antonia Lavorato, María Teresa Visentin, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 6, 2016

Thrombosis-associated antifibrinogen IgG1 κ impairs fibrin polymerization and enhances platelet activationDennis K Galanakis, Eric D Spitzer, Peter Perrotta, et al.

American Journal of Hematology|June 28, 2019

Clinical outcomes with unfractionated heparin monitored by anti-factor Xa vs. activated partial Thromboplastin timeJames C Coons, Carlo J Iasella, Megan Thornberg, et al.

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 18, 2025

Outcomes Associated with Time in Therapeutic Range for Patients Receiving Intravenous Unfractionated HeparinMujtaba Mahmud, Maia Klimatcheva, Angela Tsang, et al.

Pageof 4

Search research articles

Showing results (21-30 of 40) with videos related to

Sort By:

Pageof 4

Cancer|September 14, 2007

Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 24, 2018

The American Society of Hematology (ASH) Medical Educators Institute: a Pilot Faculty Development Project for Hematology EducatorsJennifer C Kesselheim, Charles P Clayton, Josel Fritz, et al.

Clinical Breast Cancer|January 21, 2003

Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58Roy E Smith, Stewart J Anderson, Ann Brown, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 23, 2015

Plasma from chronic liver disease subjects exhibit differential ability to generate thrombinZhineng J Yang, Siddharth H Sheth, Chad H Smith, et al.

Microsurgery|February 27, 2023

Journal of the American Heart Association|August 25, 2021

Association Between Black Race, Clinical Severity, and Management of Acute Pulmonary Embolism: A Retrospective Cohort StudyAmanda R Phillips, Katherine M Reitz, Sara Myers, et al.

Validation of a protocol for the assessment of skin temperature and blood flow in childhood localised sclerodermaKevin J Howell, Antonia Lavorato, María Teresa Visentin, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 6, 2016

Thrombosis-associated antifibrinogen IgG1 κ impairs fibrin polymerization and enhances platelet activationDennis K Galanakis, Eric D Spitzer, Peter Perrotta, et al.

American Journal of Hematology|June 28, 2019

Clinical outcomes with unfractionated heparin monitored by anti-factor Xa vs. activated partial Thromboplastin timeJames C Coons, Carlo J Iasella, Megan Thornberg, et al.

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 18, 2025

Outcomes Associated with Time in Therapeutic Range for Patients Receiving Intravenous Unfractionated HeparinMujtaba Mahmud, Maia Klimatcheva, Angela Tsang, et al.

Pageof 4